EUCTR2015-003314-24-ES进行中（未招募）1 期
A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects with Moderate to Severe Plaque Psoriasis
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Male or female 6 to 17 years of age with diagnosis of chronic plaque psoriasis
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 32
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any significant medical condition, laboratory abnormality, or psychiatric illness that would prevent the subject from participating in the study or which places subject at unacceptable riskif he/she were to participate in the study
研究者
相似试验
进行中（未招募）
不适用
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of OralOPC-34712 as Monotherapy in Adult Patients with SchizophreniaMedDRA version: 12.0Level: LLTClassification code 10039626Term: SchizophreniaschizophreniaEUCTR2009-012568-14-SKOtsuka Pharmaceutical Development & Commercialization300
进行中（未招募）
1 期
A study to evaluate the efficacy and safety of of Enzalutamide with Trastuzumab in patients with HER2+ AR+ Metastatic or Locally Advanced Breast CancerSubjects with HER2+ AR+ Metastatic or Locally Advanced Breast CancerMedDRA version: 20.0Level: PTClassification code 10065430Term: HER-2 positive breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10072740Term: Locally advanced breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-000093-29-GBAstellas Pharma Global Development, Inc.80
已完成
2 期
An open label study to assess safety and tolerability of OPC-34712 in patients with schizophrenia.CTRI/2009/091/000953Otsuka Pharmaceutical Development Commercialization300
进行中（未招募）
1 期
A study to evaluate the efficacy and safety of of Enzalutamide with Trastuzumab in patients with HER2+ AR+ Metastatic or Locally Advanced Breast CancerEUCTR2013-000093-29-ESAstellas Pharma Global Development, Inc.80
进行中（未招募）
1 期
A study to evaluate the efficacy and safety of of Enzalutamide with Trastuzumab in patients with HER2+ AR+ Metastatic or Locally Advanced Breast CancerEUCTR2013-000093-29-BEAstellas Pharma Global Development, Inc.80